About this trial
The primary purpose of this study is to follow patients with various musculoskeletal (MSK) conditions over a one-year follow-up period after receiving a platelet rich plasma (PRP) injection, assessing changes in their pain levels, functional abilities, and overall patient satisfaction.
This will develop a robust registry of patients treated with PRP for a range of MSK conditions. These conditions include, but are not limited to, osteoarthritis (OA) of the knee, hip, glenohumeral joint, elbow, ankle, and sacroiliac joint, as well as rotator cuff tendinopathy, lateral and medial epicondylitis, plantar fasciitis, patellar tendinopathy, Achilles tendinopathy, and proximal hamstring tendinopathy.
Eligibility criteria
Qualifiers
18+ years old
Musculoskeletal pathology that may benefit from a PRP injection
Failed other conservative treatments
Disqualifiers
No active malignancy
No active infection in the area of injection
No platelet disorder
No active systemic infections
Trial design
Treatments tested in this trial
- Platelet Rich Plasma Injection
- Platelet Rich Plasma Preparation